Octadecyl 3-(3, 5-di-tert-butyl-4-hydroxyphenyl) propanoate, an antifungal metabolite of Alcaligenes faecalis strain MT332429 optimized through response surface methodology.

In the current study, a soil bacterial isolate F2 expressed a significant antagonistic activity against Candida albicans ATCC 10231 and Aspergillus niger clinical isolate confirmed through cross streak, dual culture, and agar well diffusion methods. The isolate F2 was identified using phenotypic and molecular approaches as Alcaligenes (A.) faecalis MT332429. The identification and structural characterization of the antifungal compound was performed using advanced spectroscopic techniques including UV absorbance, H and C NMR and 2D NMR (COSY, HSQC, and HMBC) and was identified as octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl) propanoate. Response surface methodology (RSM) using a central composite design was employed to optimize the nutritional and cultural variables affecting the antifungal metabolite yield. The optimum conditions were found to be temperature 30 °C, agitation 150 rpm, glucose 1 g/l, peptone 2 g/l, and pH 8. A confirmatory experiment was performed to assess the accuracy of the optimization procedure, where an increase in the antifungal metabolite production by about 2.48-fold was obtained. To the best of our knowledge, this is the first report of octadecyl 3-(3, 5-di-tert-butyl-4-hydroxyphenyl) propanoate recovered from the culture broth of A. faecalis MT332429 with a promising antifungal activity along with its optimized production through RSM. KEY POINTS: • A novel soil bacterial isolate, F2, identified as Alcaligenes faecalis MT332429, showed significant antagonistic activity against Candida albicans ATCC 10231 and Aspergillus niger clinical isolate. • This stable fungicidal extracellular metabolite was identified as octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl) propanoate. • Optimization using central composite design resulted in 2.48-fold increase in production reaching 213.82 μg/ml.